Variant report
Variant | nsv524340 |
---|---|
Chromosome Location | chr4:187299297-187313377 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540558429 | chr4:187303216-187303217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373666157 | chr4:187303225-187303226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184807761 | chr4:187303229-187303230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111658280 | chr4:187303246-187303247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577006390 | chr4:187303257-187303258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7675440 | chr4:187303264-187303265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370570148 | chr4:187303290-187303291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531313983 | chr4:187303294-187303295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547846611 | chr4:187303296-187303297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10032656 | chr4:187303301-187303302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527273061 | chr4:187303362-187303363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547718068 | chr4:187303375-187303376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189749496 | chr4:187303376-187303377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs58856998 | chr4:187303378-187303379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs550112557 | chr4:187303427-187303428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181398741 | chr4:187303468-187303469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535972505 | chr4:187303472-187303473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555873220 | chr4:187303479-187303480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550148020 | chr4:187303496-187303497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370483010 | chr4:187303497-187303498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535004162 | chr4:187303530-187303531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375990013 | chr4:187303596-187303597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554080469 | chr4:187303648-187303649 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74786178 | chr4:187303692-187303693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143422225 | chr4:187303738-187303739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184355715 | chr4:187303764-187303765 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189156552 | chr4:187303783-187303784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143851554 | chr4:187303813-187303814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368873089 | chr4:187303814-187303815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181810942 | chr4:187303825-187303826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148650251 | chr4:187303887-187303888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186533671 | chr4:187303930-187303931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34656431 | chr4:187303944-187303945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6839207 | chr4:187303948-187303949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372424114 | chr4:187303957-187303958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564065212 | chr4:187303982-187303983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533467323 | chr4:187303983-187303984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541373404 | chr4:187304033-187304034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200886224 | chr4:187304051-187304052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190938344 | chr4:187304066-187304067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570179257 | chr4:187304070-187304071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150675619 | chr4:187304096-187304097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139897982 | chr4:187304103-187304104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371821564 | chr4:187304115-187304116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs143768514 | chr4:187304147-187304148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533216972 | chr4:187304164-187304165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181051455 | chr4:187304172-187304173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557875141 | chr4:187304234-187304235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571581882 | chr4:187304237-187304238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539374009 | chr4:187304324-187304325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Breast cancer | 22522925 | CNVD |
Melanoma | 20877625 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187303200-187303600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr4:187303400-187303800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr4:187303600-187313200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr4:187313200-187313400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr4:187313200-187313600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr4:187313200-187313600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr4:187313200-187313600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |